 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Easy to use |  |
 |
After nasal surgery, NasalOne® Intranasal Splint can be directly inserted to the wound site using forceps or pliers after apply with antibiotic. By absorbing nasal fluids and blood, NasalOne® Intranasal Splint can be a sufficient wound support and start degradation slowly.
After several days, NasalOne® Intranasal Splint can be removed or just flow through nasal pathway without any pain. |
 |
 |
Precautions |  |
 |
■ NasalOne® Intranasal Splint should not apply to infected area of wound site.
■ Even though NasalOne® Intranasal Splint promotes blood clotting, NasalOne® Intranasal Splint is not intended to apply patients with abnormal blood clotting. ■ The safety of NasalOne® Intranasal Splint on pregnant women is not clinically evaluated. If necessary, surgeon may use NasalOne® Intranasal Splint in pregnant women according to patient’s condition and response.. ■ NasalOne® Intranasal Splint is limited for single use only. Do not re-sterilize or re-use "NasalOne®" Intranasal Splint. |
 |
 |
Storage: |  |
 |
‧Stored at dry place below 25℃. Don’t expose NasalOne® Intranasal Splint to extreme environmental conditions. ‧Shelf life is 2 years if stored at roomtemperature. |
 |
 |
 |
MedFront Medical Technology Corporation Address：3F., No.3-3, Lane 27, Sec 2, Jhongshan N Rd., Jhongshan District,Taipei, 104, Taiwan, R.O.C. |
Manufacturing company：Maxigen Biotech Inc. Address：No.17. Wuchiuan 8thRd., Wugu District(New Taipei Industrial Park), New Taipei City 24891, Taiwan, R.O.C. |
 |
 |
Product information contained in this website is for use by general users through some product details or data, some of which might be unable to reach or to be invalid. |  |
 |